SUN-657 - Prevalence of Poor sleep quality among patients with type 2 Diabetes Mellitus : A Cross Sectional Study PREVALANCE OF POOR SLEEP QUALITY AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY.

PREVALANCE OF POOR SLEEP QUALITY AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY.



ABSTRACT:

Background: Sleep disturbances are increasingly recognized among patients with diabetes mellitus and may adversely affect glycemic control and quality of life.

Objective: To determine the prevalence of poor sleep quality and its association with various demographic and clinical variables among patients with type 2 diabetes mellitus and devise a non pharmacological strategy for glycemic control in type 2 diabetics.

Methods: A cross-sectional study was conducted among 109 patients with type 2 diabetes mellitus. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Participants were categorized as good or poor sleepers based on PSQI scores. Statistical analysis was performed using Jamovi software, with independent t-tests, chi-square tests, and logistic regression analysis applied as appropriate.

Results: Poor sleep quality was highly prevalent and observed in 68.8% of the participants. No statistically significant association was found between sleep quality and variables such as age, body mass index, random blood sugar levels, duration of treatment, sex, insulin therapy, oral hypoglycemic agent use, or diabetic neuropathy (p > 0.05). Despite the above results, OHA use showed borderline statistical significance with Poor sleep quality (p=0.07) which warrants a larger prospective clinical investigation to fully know the consequences and associations of poor sleep quality in type 2 Diabetics.

Conclusion: Poor sleep quality is highly prevalent among patients with type 2 diabetes mellitus. Routine screening for sleep disturbances can help improve overall diabetes management and patient outcomes with improved quality of life.

*Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*